Continuous Glucose Monitoring-Measured Glucose Levels During Oral Glucose Tolerance Testing in Pregnancy
- 2 June 2025
- journal article
- Published by SAGE Publications in Diabetes Technology & Therapeutics
- Vol. 27 (6) , 439-448
Abstract
Background: To diagnose gestational diabetes mellitus (GDM), clinicians typically rely on the oral glucose tolerance test (OGTT). Continuous glucose monitoring (CGM) is a tool that could possibly be used to complement or replace the OGTT. Our aim is to describe CGM-derived glycemic patterns observed concurrently during the administration of a diagnostic OGTT in pregnancy. Methods: In total, 119 pregnant females underwent OGTT testing while wearing a blinded CGM sensor. Blood glucose (BG) measurements collected during the OGTT were compared with CGM-measured glucose values obtained using a Dexcom G6 Pro sensor to determine the differences between CGM-measured and BG levels during the OGTT, measure glycemic excursion during the OGTT, and determine differences in GDM diagnosis using standard BG draws during OGTT versus CGM-measured glucose levels. Results: CGM-measured glucose levels were on average higher than paired BG levels during the OGTT at each timed measurement (fasting, 1-, 2- and 3-h); fasting CGM-measured glucose levels in particular were higher than fasting BG levels by 6 ± 13 mg/dL. The median CGM minus BG-measured glycemic excursion during the OGTT was 12 and 4 mg/dL for the 75 g and 100 g OGTT, respectively. Of 28 participants diagnosed with GDM based on OGTT BG levels, 24 (86%) participants would have been diagnosed as GDM using CGM with BG-based thresholds; of 91 participants not diagnosed with GDM, 54 (59%) would also have not been diagnosed with GDM using CGM. Conclusions: CGM glucose measurements using Dexcom G6 Pro tended to be slightly higher than BG values during an OGTT, leading to more participants who would have been diagnosed with GDM if the BG-based OGTT thresholds were applied to these CGM-measured glucose values. When CGM is used for GDM diagnosis, diagnostic glucose criteria may need to be specific for the type of sensor used accounting for any bias in glucose measurement.Keywords
This publication has 17 references indexed in Scilit:
- Performance of the Dexcom G7 Continuous Glucose Monitoring System in Pregnant Women with DiabetesDiabetes Technology & Therapeutics, 2024
- Pregnant women’s experience of undergoing an oral glucose tolerance test: A cross-sectional studyDiabetes Research and Clinical Practice, 2022
- IDF Diabetes Atlas: Estimation of Global and Regional Gestational Diabetes Mellitus Prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group’s CriteriaDiabetes Research and Clinical Practice, 2022
- Continuous Glucose Monitoring in Women with Normal OGTT in PregnancyJournal of Diabetes Research, 2021
- Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with DiabetesDiabetes Technology & Therapeutics, 2020
- Performance of a Factory-Calibrated Real-Time Continuous Glucose Monitoring System Utilizing an Automated Sensor ApplicatorDiabetes Technology & Therapeutics, 2018
- Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with DiabetesDiabetes Technology & Therapeutics, 2018
- Hyperglycemia and Adverse Pregnancy OutcomesNew England Journal of Medicine, 2008
- Association between Gestational Diabetes and Pregnancy-induced HypertensionAmerican Journal of Epidemiology, 2003
- Pregnancy Outcomes in Women With Gestational Diabetes Compared With the General Obstetric PopulationObstetrics & Gynecology, 1997